---
figid: PMC4975146__dddt-10-2443Fig3
figtitle: 'Signal transducer and activator of transcription tyrosine kinase domain
  c-Kit in cancer cell.Notes: The Ras-Erk pathway, PI3K/AKT pathway, and Src-signaling
  pathway have been demonstrated in this schematic picture'
organisms:
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Sus scrofa
- Homo sapiens
- unidentified
- NA
pmcid: PMC4975146
filename: dddt-10-2443Fig3.jpg
figlink: /pmc/articles/PMC4975146/figure/f3-dddt-10-2443/
number: F3
caption: 'Signal transducer and activator of transcription tyrosine kinase domain
  c-Kit in cancer cell.Notes: The Ras-Erk pathway, PI3K/AKT pathway, and Src-signaling
  pathway have been demonstrated in this schematic picture. Although each of the signaling
  pathways goes through different ways and has different effects on cell function,
  the result of all of three pathways is inhibition of the cell apoptosis, resulting
  in tumorogenesis in different ways, such as inducing of cell proliferation, growth
  progression, or migration. Moreover, the mechanisms of c-Kit inhibitor drugs have
  been shown. Each group of c-Kit inhibitor drugs block different targets, which have
  been highlighted in red.'
papertitle: 'Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic
  target in cancer cells.'
reftext: Maryam Abbaspour Babaei, et al. Drug Des Devel Ther. 2016;10:2443-2459.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9627718
figid_alias: PMC4975146__F3
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Sus scrofa
- Bos taurus
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC4975146__F3
ndex: 87c59fa1-deaf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4975146__dddt-10-2443Fig3.html
  '@type': Dataset
  description: 'Signal transducer and activator of transcription tyrosine kinase domain
    c-Kit in cancer cell.Notes: The Ras-Erk pathway, PI3K/AKT pathway, and Src-signaling
    pathway have been demonstrated in this schematic picture. Although each of the
    signaling pathways goes through different ways and has different effects on cell
    function, the result of all of three pathways is inhibition of the cell apoptosis,
    resulting in tumorogenesis in different ways, such as inducing of cell proliferation,
    growth progression, or migration. Moreover, the mechanisms of c-Kit inhibitor
    drugs have been shown. Each group of c-Kit inhibitor drugs block different targets,
    which have been highlighted in red.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Kit
  - Pten
  - Src
  - Akt1
  - Pdk1
  - Grb2
  - Pck1
  - Tp53
  - Rapgef1
  - Pik3cg
  - Braf
  - Mapk8
  - Mapk7
  - Mapk1
  - Mapk14
  - Reg3b
  - Ephb1
  - Bcl2l1
  - Ccnd1
  - Bcl2
  - Mcl1
  - Il4r
  - Slc2a1
  - Slc1a3
  - Cish
  - Socs1
  - Socs3
  - Socs2
  - KIT
  - PTEN
  - SRC
  - AKT1
  - PDK1
  - GRB2
  - TP53
  - BRAF
  - MAPK8
  - MAPK1
  - CCND1
  - BCL2
  - MCL1
  - IL2RA
  - SLC2A1
  - CISH
  - SOCS1
  - SOCS3
  - SOCS2
  - PIK3CB
  - MAPK7
  - MAPK14
  - BCL2L1
  - Pik3ca
  - Pdpk1
  - Shc1
  - Trp53
  - Terf2ip
  - Rap1a
  - Zhx2
  - Pik3r1
  - Mdk
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - Rp9
  - Ephb2
  - Il2ra
  - Il4ra
  - Il3ra
  - Cs
  - NPY6R
  - FGR
  - FYN
  - YES1
  - XYLT2
  - SOS1
  - SOS2
  - AKT2
  - AKT3
  - CUX1
  - SART3
  - PDPK1
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - MTG1
  - TP63
  - TP73
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - RAPGEF1
  - ZHX2
  - ARAF
  - RAF1
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK9
  - MAPK10
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - RP9
  - EPHB2
  - MAPK3
  - ISG20
  - IL4R
  - IL3RA
  - Midostaurin
  - Pazopanib
  - Cancer
  - Lung cancer
  - Noonan syndrome
---
